New hope for kids who Can't stay dry: major trial tests drug combo
NCT ID NCT06551246
Summary
This study aims to find the best medication plan to help children aged 5 to 14 who struggle with daytime wetting (overactive bladder). Researchers are comparing two different drugs, solifenacin and mirabegron, given alone at a higher dose or together at lower doses, to see which approach is most effective at reducing accidents. The goal is to improve bladder control with fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY INCONTINENCE IN CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Pediatric and Adolescent Medicine, Aalborg University Hospital
RECRUITINGAalborg, Aalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Pediatric and Adolescent Medicine, Aarhus University Hospital
RECRUITINGAarhus, Aarhus N, 8200, Denmark
Contact
Contact Email: •••••@•••••
-
Department of Pediatric and Adolescent Medicine, Gødstrup Hospital
RECRUITINGHerning, Herning, 7400, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Pediatric and Adolescent Medicine, Kolding Hospital
RECRUITINGKolding, Kolding, 6000, Denmark
Contact Email: •••••@•••••
-
Department of Pediatric and Adolescent medicine, Esbjerg Hospital
RECRUITINGEsbjerg, Esbjerg, 6700, Denmark
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.